64.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$63.54
Aprire:
$63.4
Volume 24 ore:
563.27K
Relative Volume:
0.24
Capitalizzazione di mercato:
$8.81B
Reddito:
$550.17M
Utile/perdita netta:
$201.35M
Rapporto P/E:
64.31
EPS:
1
Flusso di cassa netto:
$232.07M
1 W Prestazione:
-2.91%
1M Prestazione:
+4.17%
6M Prestazione:
-16.13%
1 anno Prestazione:
+84.84%
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Confronta DOCS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DOCS
Doximity Inc
|
64.31 | 11.99B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
VEEV
Veeva Systems Inc
|
278.55 | 45.62B | 2.86B | 780.66M | 1.19B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
72.92 | 12.10B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
HQY
Healthequity Inc
|
90.19 | 7.72B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.82 | 6.16B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2024-12-20 | Iniziato | Stephens | Equal-Weight |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-11-15 | Iniziato | Goldman | Neutral |
2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
2024-08-09 | Aggiornamento | Needham | Hold → Buy |
2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
2023-08-09 | Downgrade | Needham | Buy → Hold |
2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2022-10-31 | Iniziato | Wells Fargo | Overweight |
2022-10-24 | Iniziato | Evercore ISI | In-line |
2022-10-13 | Iniziato | BTIG Research | Neutral |
2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2022-09-07 | Iniziato | Truist | Hold |
2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
2022-07-28 | Iniziato | Berenberg | Buy |
2022-05-18 | Reiterato | BofA Securities | Neutral |
2022-05-18 | Reiterato | Goldman | Buy |
2022-05-18 | Reiterato | Guggenheim | Buy |
2022-05-18 | Reiterato | Jefferies | Buy |
2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
2022-05-18 | Reiterato | Needham | Buy |
2022-04-07 | Iniziato | Guggenheim | Buy |
2022-04-04 | Iniziato | BofA Securities | Neutral |
2022-02-11 | Iniziato | Goldman | Buy |
2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
2021-12-02 | Iniziato | Jefferies | Buy |
2021-11-17 | Iniziato | Robert W. Baird | Outperform |
2021-11-10 | Reiterato | Canaccord Genuity | Buy |
2021-11-10 | Reiterato | Goldman | Neutral |
2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
2021-11-10 | Reiterato | Needham | Buy |
2021-11-10 | Reiterato | Piper Sandler | Overweight |
2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
2021-07-19 | Iniziato | Canaccord Genuity | Buy |
2021-07-19 | Iniziato | Goldman | Neutral |
2021-07-19 | Iniziato | JP Morgan | Overweight |
2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
2021-07-19 | Iniziato | Piper Sandler | Overweight |
2021-07-19 | Iniziato | Raymond James | Outperform |
2021-07-19 | Iniziato | SVB Leerink | Outperform |
2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
We Think Doximity's (NYSE:DOCS) Profit Is Only A Baseline For What They Can Achieve - simplywall.st
Deutsche Bank AG Sells 700,949 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Price Target Raised to $69.00 - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Director Sells $315,000.00 in Stock - MarketBeat
LPL Financial LLC Has $6.22 Million Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Shares Down 6.5% After Insider Selling - MarketBeat
Blair William & Co. IL Sells 10,592 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Vanguard Group Inc. Acquires 990,923 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity’s Earnings Call Highlights Growth and AI Advances - MSN
Doximity’s Q2 Earnings Call: Our Top 5 Analyst Questions - TradingView
Doximity, Inc. (NASDAQ:DOCS) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
DigitalOcean, Doximity, Freshworks, Braze, and Teradata Stocks Trade Up, What You Need To Know - Yahoo Finance
Doximity (NASDAQ:DOCS) Given New $59.00 Price Target at Canaccord Genuity Group - MarketBeat
Sierra Summit Advisors LLC Purchases New Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
191,798 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by AGF Management Ltd. - MarketBeat
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
Bank of Nova Scotia Makes New $651,000 Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
DOCS- A Healthcare Play That's on the Move After Beat-and-Raise Quarter - Yahoo Finance
Doximity buys AI clinical reference startup Pathway for $63 million - DOTmed
(08/13/25) DOCS: A Healthcare Play That’s on the Move After Beat-and-Raise - moneyshow.com
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Call Transcript - MSN
Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm - MSN
Jefferies Financial Group Inc. Sells 13,195 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity acquires AI-powered clinical decision support tool - TechTarget
Doximity Buying Pathway In $63 Million Deal - Pulse 2.0
DOCS Q2 Deep Dive: AI Investment, Product Expansion, and Broad-Based Customer Momentum - TradingView
What makes Doximity Inc. stock price move sharplyOversold Recovery Picks - thegnnews.com
Doximity, Inc. (NASDAQ:DOCS) Shares Acquired by Natixis Advisors LLC - MarketBeat
Analysts Weigh In on Green Thumb Industries, Doximity, and BioLife Solutions - AInvest
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Doximity Plummets 6.4%: What's Fueling the Selloff? - AInvest
Doximity (NASDAQ:DOCS) Announces Earnings Results - MarketBeat
Doximity (DOCS) Is Up 14.2% After AI Acquisition and Revenue BeatWhat's Changed - simplywall.st
Doximity outlines 11% full-year revenue growth target as AI suite and Pathway acquisition accelerate platform expansion - MSN
Doximity (NASDAQ:DOCS) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Doximity (NASDAQ:DOCS) Price Target Raised to $75.00 at Needham & Company LLC - MarketBeat
Doximity First Quarter 2026 Earnings: Beats Expectations - Yahoo Finance
Doximity Shares Surge as Strategic Moves and Strong Earnings Impress Investors - timothysykes.com
10 Stocks with Eye-Popping Gains; 5 Jump to New Highs - Insider Monkey
Mackenzie Financial Corp Cuts Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
U.S. Indexes Rose Friday; Doximity Topped Leaders - Barron's
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):